United States pharmacopeia safety evaluation of spirulina.
about
The effect of Arthrospira platensis capsules on CD4 T-cells and antioxidative capacity in a randomized pilot study of adult women infected with human immunodeficiency virus not under HAART in Yaoundé, Cameroon.Analysis of β-N-methylamino-L-alanine (BMAA) in spirulina-containing supplements by liquid chromatography-tandem mass spectrometry.Dietary algae and HIV/AIDS: proof of concept clinical dataModulating Effects of Spirulina platensis against Tilmicosin-Induced Cardiotoxicity in MiceBlue-Green Algae Inhibit the Development of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice.Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease.Well-tolerated Spirulina extract inhibits influenza virus replication and reduces virus-induced mortality.Antioxidant, Immunomodulating, and Microbial-Modulating Activities of the Sustainable and Ecofriendly Spirulina.Dietary supplements: health from the ocean?The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview.Microalgal food supplements from the perspective of Polish consumers: patterns of use, adverse events, and beneficial effects.Study and Understanding Behavior of Alginate-Inulin Synbiotics Beads for Protection and Delivery of Antimicrobial-Producing Probiotics in Colonic Simulated Conditions.Edible Cyanobacterial Genus Arthrospira: Actual State of the Art in Cultivation Methods, Genetics, and Application in Medicine.Neuroprotective effect of Arthrospira (Spirulina) platensis against kainic acid-neuronal death.Inhibitory effects of spirulina platensis on carcinogen-activating cytochrome P450 isozymes and potential for drug interactions.Preparation, characterization and evaluation of physicochemical properties of phycocyanin-loaded solid lipid nanoparticles and nanostructured lipid carriers
P2860
Q33963346-2D478D5F-DEB5-4801-9316-E7FCFF040E67Q34033092-D93CC461-1FB9-4537-93D5-283A8A3C7C05Q34290746-471E967A-CF45-4C50-8687-8705B053C6DCQ35369398-03F611CD-05DE-45C5-AED7-65F902FF88BEQ36388450-2CA7F4BD-F22D-448C-B8BC-0B34978CF23DQ36623024-3D2F3651-BFA6-4456-88DE-89A01F829513Q36789802-B10402B5-337C-45B6-93C3-8285D109BB21Q37611265-E39B273D-F96F-4E90-9328-5BC03734505BQ38579248-8C4998AC-99B7-4A20-A32A-A433D8471ECBQ38853168-043FF83B-FA29-48E9-851D-72CF179023A1Q41039491-0DD7A6AA-EE34-437F-B4F6-325D9EB29818Q47357334-9BB2AB58-A3FD-4B84-B268-2B654EFC1D17Q48503146-25890105-592A-41B3-9D6D-C77B0492478FQ48955788-90066B70-5338-48AD-B996-41E9D4022008Q53248633-C6DE486D-AF18-42C1-96AD-27342C40D6C8Q58207126-F154B8F9-BD52-450C-AAA3-5709B44A1D80
P2860
United States pharmacopeia safety evaluation of spirulina.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
United States pharmacopeia safety evaluation of spirulina.
@en
United States pharmacopeia safety evaluation of spirulina.
@nl
type
label
United States pharmacopeia safety evaluation of spirulina.
@en
United States pharmacopeia safety evaluation of spirulina.
@nl
prefLabel
United States pharmacopeia safety evaluation of spirulina.
@en
United States pharmacopeia safety evaluation of spirulina.
@nl
P2093
P2860
P50
P1476
United States pharmacopeia safety evaluation of spirulina.
@en
P2093
Gabriel I Giancaspro
Gail B Mahady
James Griffiths
Maged Sharaf
Marilyn L Barrett
Mary L Chavez
Nandakumara D Sarma
Richard Ko
Tieraona Low Dog
P2860
P304
P356
10.1080/10408391003721719
P577
2011-08-01T00:00:00Z